FEATURED CONTRIBUTED CONTENT

Case Study: Co-Pay Card Program Optimization Saves Manufacturer $13M


Case Study: Co-Pay Card Program Optimization Saves Manufacturer $13M

Those who run co-pay programs often see them as absolute–something they employ as part of their strategy, and from which the impact is easily understood. The reality is, however, that co-pay programs work to varying degrees. Simply having one will attract more patients, but its mere presence doesn’t make it a success. Improperly designed business rules […]

April 28, 2016More Clinical »
Save Millions in Reimbursement Costs with Co-Pay Card Program Optimization


Save Millions in Reimbursement Costs with Co-Pay Card Program Optimization

This podcast episode discusses some of the environmental factors reinforcing the importance of co-pay program optimization and goes into detail on the various aspects of the program that can be optimized and common results.  A real-world example of a program optimization analysis is discussed, featuring one manufacturer’s challenges and TrialCard’s approach for optimizing. There is […]

April 29, 2016More Clinical »
Evolution or Revolution?  How Life Sciences organizations are transforming to meet the evolving US healthcare market needs


Evolution or Revolution? How Life Sciences organizations are transforming to meet the evolving US healthcare market needs

Whether you call it an evolution or a revolution, the US Healthcare market is going through considerable change.  Since the HITECH Act in 2009 and the Affordable Care Act in 2010, we have seen significant consolidation of provider organizations and the introduction of many new decision-makers and key influencers. Healthcare organizations are using the wealth […]

February 15, 2016More Clinical »
HBAdvantage: Transforming the Future – March 2016


HBAdvantage: Transforming the Future – March 2016

The HBA is embarking on a bold approach to transform the future of the healthcare industry: achieve gender parity. This issue of HBAdvantage focuses on numerous related issues. This pivot in direction first began in 2015 as the HBA’s board of directions re-evaluated the organization’s strategic plan based on feedback from key members of its advisory […]

March 29, 2016More Clinical »
Digitization Across Borders: Opening New Markets, the Paperless Way


Digitization Across Borders: Opening New Markets, the Paperless Way

Your business, your patients, and your supply chain are all global and mobile – so it’s no surprise that over 80% of life science executives are investing in a globally integrated supply chain and collaborative business models. Pharmaceutical leaders are embracing fully digital processes to efficiently run clinical trials, manage distribution, and ensure quality at […]

May 3, 2016More Clinical »
Hallux Selects ClinCapture For Ease-Of-Use And Team Responsiveness


Hallux Selects ClinCapture For Ease-Of-Use And Team Responsiveness

The California-based pharmaceutical company is developing a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis (toenail fungus). “We are currently testing in the clinic using the ClinCapture EDC system” explains Hendrik Arend Kroon, MD MBA, CMO and Executive Vice President at Hallux Inc. “What stood out for me first […]

March 31, 2016More Clinical »
Highlights from podcast on demonstrating value in oncology research


Highlights from podcast on demonstrating value in oncology research

In a recent podcast, Kathleen McConnell and Jason McDonough of Cello Health Communications shared their thoughts on how companies in oncology research can demonstrate value to to stakeholders. Here are some of the key points from the podcast. “We really believe the biggest challenge that’s occurring now is that the era of truly transformative therapies” “The […]

March 1, 2016More Clinical »
Implementing a Clinical Data Repository and Analytics Platform in 90 Days


Implementing a Clinical Data Repository and Analytics Platform in 90 Days

Leveraging clinical trial data to decrease risk, time, and cost. Clinical trial data is critical to bring new treatments to market quickly and in a cost-effective manner. Clinical trial data is the most valuable asset for life sciences companies. However, companies struggle to leverage their data to make better decisions and to decrease the time […]

March 17, 2016More Clinical »
What I love about this Digital Health white paper


What I love about this Digital Health white paper

White papers often summarize larger sources of information, usually from research studies. Cello Health Insight released a white paper recently that contains a number of interesting findings from their study on digital health technology. It is chock full of intriguing facts about doctors in health care, and shows us how technology is becoming more important every day. […]

February 19, 2016More Clinical »
Regulatory Application of Standard for Exchange of Nonclinical Data (SEND)


Regulatory Application of Standard for Exchange of Nonclinical Data (SEND)

Standard for Exchange of Nonclinical Data (SEND) is a new formatting requirement for the submission of electronic data to the FDA. This initiative is led by the Clinical Data Interchange Standards Consortium (CDISC) with the intent to integrate clinical Study Data Tabulation Models (SDTM) into nonclinical data submissions. SEND creates structured organization and terminology for […]

April 19, 2016More Clinical »
Improving Marketing Performance With Behavioral Insights


Improving Marketing Performance With Behavioral Insights

There are three valuable benefits of using behavioral insights when planning a marketing program. First, they provide validated models for better predicting human behavior, as opposed to personal opinions or guesswork. Second, they reveal how non-rational and non-conscious factors influence decisions and behaviors. Third, they provide a conceptual basis for developing campaigns that have the potential to deliver better […]

February 29, 2016More Clinical »
How Pharma can turn the trend of the decade into a leadership advantage


How Pharma can turn the trend of the decade into a leadership advantage

The World Economic Forum has named collaboration as the key to global growth: public-private partnerships between companies large and small, NGOs, government agencies and academia are the single largest corporate trend of the decade. And why? The world’s problems are increasingly those that can only be solved by the best and brightest from a wide […]

March 1, 2016More Clinical »
Collaboration: Trend of the Decade podcast overview


Collaboration: Trend of the Decade podcast overview

I recently talked with Johanna Skilling from Ogilvy CommonHealth Worldwide about what she calls the trend of the decade for pharma; Collaboration. Johanna provides numerous examples to illustrate her points. Here are some of her thoughts. “We have and we tackle the most intimate critical problems from big viruses to public health epidemics, to long-term […]

March 14, 2016More Clinical »
Genetically-modified mosquitoes become a weapon against Zika


Genetically-modified mosquitoes become a weapon against Zika

Nobody likes mosquitoes. They can ruin an otherwise pleasant summer day. However, mosquitoes present even greater harm when they spread disease. By their nature, they are one of the most perfect disease-spreaders in the world. They carry blood-borne diseases, such a Malaria and Zika. They can travel across continents as stowaways. They reproduce in great quantities. They are […]

March 15, 2016More Clinical »
Utilizing Behavioral Insights for Healthcare Marketing


Utilizing Behavioral Insights for Healthcare Marketing

In this episode, Mr. Petito defines behavioral insights,and provides examples and case studies of how behavioral insights can be used in healthcare marketing with providers and patients. Also, please download our related white paper on this subject, using the link at the bottom of this listing.

February 29, 2016More Clinical »
FEEDBACK